Assessing Diagnostics At Point-of-care for Tuberculosis

NARecruitingINTERVENTIONAL
Enrollment

1,350

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
Tuberculosis
Interventions
DIAGNOSTIC_TEST

Tongue swab-based molecular assays

The investigators will evaluate semi-automated or automated molecular assays intended for use at near point of care or point of care.

Trial Locations (3)

Unknown

RECRUITING

Zankli Research Center, Bingham University, Abuja

RECRUITING

De La Salle Medical and Health Sciences Institute, Dasmariñas

RECRUITING

Centre for Infectious Disease Research in Zambia, Lusaka

All Listed Sponsors
collaborator

University Hospital Heidelberg

OTHER

collaborator

KNCV Tuberculosis Foundation

OTHER

collaborator

Bingham University

UNKNOWN

collaborator

University of California, Irvine

OTHER

collaborator

De La Salle University Medical Center

OTHER

collaborator

Centre for Infectious Disease Research in Zambia

OTHER

collaborator

Johns Hopkins University

OTHER

lead

University of California, San Francisco

OTHER